Neuroblastoma, a devastating cancer affecting primarily children under five, stands as one of the most aggressive solid tumors in pediatric populations, with high-risk cases often showing dismal outcomes despite rigorous treatments. With only about half of these young patients achieving a cure
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a keen understanding of tech and innovation, has positioned him at the forefront of groundbreaking advancements in cancer treatment. Today, we’re diving into
The biotechnology sector often rides a rollercoaster of high hopes and sharp setbacks, and few cases illustrate this better than the recent plunge in Exelixis’ stock value following the release of data from its STELLAR-303 trial. Focused on zanzalintinib, an experimental drug for metastatic
As we dive into the complex world of healthcare policy, I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose deep understanding of technology and innovation in the industry, coupled with extensive experience in research and development, offers invaluable insights. Today,
Imagine a world where the brain's fundamental energy processes, long thought to be set in stone, are suddenly redefined by a single discovery that could alter the course of treatment for devastating neurological conditions. Researchers from prestigious institutions have recently unveiled a
In the heart of Wirral, UK, a cherished annual tradition is gearing up to bring holiday cheer and hope to countless lives through the Wirral Bazaar, hosted by North West Cancer Research at Hulme Hall in Port Sunlight on November 3 and 4. This festive event, steeped in over three decades of history,
